Quantitative evaluation and countermeasure suggestions on support policies for the development of traditional Chinese medicine preparations in medical institutions in China
- VernacularTitle:我国医疗机构中药制剂发展支持政策的量化评价及对策建议
- Author:
Shanying WU
1
;
Jia LI
1
;
Wenxue YU
1
;
Qingyan WU
1
Author Information
1. School of Medical Business，Guangdong Pharmaceutical University，Guangzhou 510006，China
- Publication Type:Journal Article
- Keywords:
medical institutions;
traditional Chinese medicine preparations;
policy texts;
PMC index model;
quantitative
- From:
China Pharmacy
2026;37(15):1937-1942
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To provide reference for the optimization of support policies for the development of traditional Chinese medicine preparations in medical institutions in China. METHODS Based on 102 policy documents concerning the support policies for the development support of traditional Chinese medicine preparations in medical institutions issued by the central government and 5 autonomous regions， text information was mined by ROST CM6 software， and a policy modeling consistency （PMC） index model was constructed. From the perspective of the whole life cycle， a multi-dimensional evaluation was carried out on the support policies for the development of traditional Chinese medicine preparations in medical institutions， and 48 policies closely related to the development of traditional Chinese medicine preparations in medical institutions were screened for empirical research. RESULTS & CONCLUSIONS The average PMC index of the 48 policies was 5.90， which was generally at a good level. Among them， 8 policies were excellent， 29 were good， 11 were acceptable， and no policies were rated poor. The policy samples performed well in the dimensions of policy orientation and policy evaluation， while some policies need to be further improved in terms of policy nature， policy instruments and policy content. It is suggested to establish a multi-level policy support system， strengthen financial support and transformation incentives of new drugs， so as to boost the high-quality development of traditional Chinese medicine preparations in medical institutions.
